Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
Robert Roskoski
Topics & Concepts
PharmacologyMedicineTyrosine kinaseKinaseImatinibCancer researchChemistryInternal medicineReceptorBiochemistryMyeloid leukemiaChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchPI3K/AKT/mTOR signaling in cancer